Yoshimi Endo Greer (Yoshimi E Greer)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Randomized Controlled Trial

Cancer Stem Cells

Top Venues

Cancer gene therapy

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Kei Kudo, Yoshimi Endo Greer, Teruhiko Yoshida, Brittney S Harrington, Soumya Korrapati, Yusuke Shibuya, Leah Henegar, Jeffrey B Kopp, Takeo Fujii, Stanley Lipkowitz, Christina M Annunziata
Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancer. Cancer gene therapy 31 (5) (2024)
Kei Kudo, Yoshimi Endo Greer, Teruhiko Yoshida, Brittney S Harrington, Soumya Korrapati, Yusuke Shibuya, Leah Henegar, Jeffrey B Kopp, Takeo Fujii, Stanley Lipkowitz, Christina M Annunziata
Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancer. Cancer gene therapy 31 (5) (2024)
Kei Kudo, Yoshimi Endo Greer, Teruhiko Yoshida, Brittney S Harrington, Soumya Korrapati, Yusuke Shibuya, Leah Henegar, Jeffrey B Kopp, Takeo Fujii, Stanley Lipkowitz, Christina M Annunziata
Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancer. Cancer gene therapy 31 (5) (2024)
Kei Kudo, Yoshimi Endo Greer, Teruhiko Yoshida, Brittney S Harrington, Soumya Korrapati, Yusuke Shibuya, Leah Henegar, Jeffrey B Kopp, Takeo Fujii, Stanley Lipkowitz, Christina M Annunziata
Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancer. Cancer gene therapy 31 (5) (2024)
Kei Kudo, Yoshimi Endo Greer, Teruhiko Yoshida, Brittney S Harrington, Soumya Korrapati, Yusuke Shibuya, Leah Henegar, Jeffrey B Kopp, Takeo Fujii, Stanley Lipkowitz, Christina M Annunziata
Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancer. Cancer gene therapy (2024)
Manjari Kundu, Yoshimi Endo Greer, Alexei Lobanov, Lisa A Ridnour, Renee N Donahue, Yeap Ng, Shashi Ratnayake, Donna Voeller, Sarah Weltz, Qingrong Chen, Stephen J Lockett, Maggie Cam, Daoud Meerzaman, David A Wink, Roberto Weigert, Stanley Lipkowitz
TRAIL-induced cytokine production via NFKB2 pathway promotes neutrophil chemotaxis and immune suppression in triple negative breast cancers. bioRxiv : the preprint server for biology (2024)
Rohan Wedam, Yoshimi Endo Greer, David J Wisniewski, Sarah Weltz, Manjari Kundu, Donna Voeller, Stanley Lipkowitz
Targeting Mitochondria with ClpP Agonists as a Novel Therapeutic Opportunity in Breast Cancer. Cancers 15 (7) (2023)
Manjari Kundu, Yoshimi Endo Greer, Jennifer L Dine, Stanley Lipkowitz
Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy. Cells 11 (23) (2022)
Manjari Kundu, Yoshimi Endo Greer, Jennifer L Dine, Stanley Lipkowitz
Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy. Cells 11 (23) (2022)
Manjari Kundu, Yoshimi Endo Greer, Jennifer L Dine, Stanley Lipkowitz
Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy. Cells 11 (23) (2022)
Manjari Kundu, Yoshimi Endo Greer, Jennifer L Dine, Stanley Lipkowitz
Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy. Cells 11 (23) (2022)